Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Long-term tolterodine reduces incontinence, is well tolerated

Aug. 30, 1999

Ferring's antidiuretic agent F-992 evaluated in healthy volunteers

Aug. 26, 1999

ACS news: Wyeth-Ayerst investigates agents for urinary incontinence

Aug. 23, 1999

Sanofi-Synthelabo submits MAA for Ditropan XL in the U.K.

Aug. 16, 1999

Leading BPH treatment to be copromoted by Abbott and Boehringer Ingelheim

Aug. 16, 1999

NexMed reports results from multiple-use study of topical alprostadil cream

Aug. 16, 1999

NIH initiates interstitial cystitis trial

Aug. 16, 1999

Phase II testing of Alexion's C5 complement inhibitor also begins in renal diseases

Aug. 12, 1999

FDA puts hold on clinical study of Vasomax

Aug. 12, 1999

BioSpecifics Technologies announces positive preliminary results in Peyronie's disease therapy

Aug. 11, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...